These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 11589831)

  • 1. Systematic determination of the packaging limit of lentiviral vectors.
    Kumar M; Keller B; Makalou N; Sutton RE
    Hum Gene Ther; 2001 Oct; 12(15):1893-905. PubMed ID: 11589831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
    Bell AJ; Fegen D; Ward M; Bank A
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent inhibition of human immunodeficiency virus type 1 replication by conditionally replicating human immunodeficiency virus-based lentiviral vectors expressing envelope antisense mRNA.
    Mautino MR; Morgan RA
    Hum Gene Ther; 2000 Sep; 11(14):2025-37. PubMed ID: 11020801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A stable system for the high-titer production of multiply attenuated lentiviral vectors.
    Klages N; Zufferey R; Trono D
    Mol Ther; 2000 Aug; 2(2):170-6. PubMed ID: 10947945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins.
    Pacchia AL; Adelson ME; Kaul M; Ron Y; Dougherty JP
    Virology; 2001 Mar; 282(1):77-86. PubMed ID: 11259192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new-generation stable inducible packaging cell line for lentiviral vectors.
    Farson D; Witt R; McGuinness R; Dull T; Kelly M; Song J; Radeke R; Bukovsky A; Consiglio A; Naldini L
    Hum Gene Ther; 2001 May; 12(8):981-97. PubMed ID: 11387062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.
    Demaison C; Parsley K; Brouns G; Scherr M; Battmer K; Kinnon C; Grez M; Thrasher AJ
    Hum Gene Ther; 2002 May; 13(7):803-13. PubMed ID: 11975847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the titer and infectivity of lentiviral vectors.
    Logan AC; Nightingale SJ; Haas DL; Cho GJ; Pepper KA; Kohn DB
    Hum Gene Ther; 2004 Oct; 15(10):976-88. PubMed ID: 15585113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64.
    Kumar M; Bradow BP; Zimmerberg J
    Hum Gene Ther; 2003 Jan; 14(1):67-77. PubMed ID: 12573060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introducing a cleavable signal peptide enhances the packaging efficiency of lentiviral vectors pseudotyped with Japanese encephalitis virus envelope proteins.
    Liu H; Wu R; Yuan L; Tian G; Huang X; Wen Y; Ma X; Huang Y; Yan Q; Zhao Q; Cao S; Wen X
    Virus Res; 2017 Feb; 229():9-16. PubMed ID: 27993624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.
    Haas DL; Case SS; Crooks GM; Kohn DB
    Mol Ther; 2000 Jul; 2(1):71-80. PubMed ID: 10899830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of murine leukemia virus, human immunodeficiency virus, and adeno-associated virus vectors for gene transfer in multiple myeloma: lentiviral vectors demonstrate a striking capacity to transduce low-proliferating primary tumor cells.
    De Vos J; Bagnis C; Bonnafoux L; Requirand G; Jourdan M; Imbert MC; Jourdan E; Rossi JF; Mannoni P; Klein B
    Hum Gene Ther; 2003 Dec; 14(18):1727-39. PubMed ID: 14670124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
    Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
    Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of lentiviral vectors for transducing cells from the central nervous system.
    Li M; Husic N; Lin Y; Snider BJ
    J Vis Exp; 2012 May; (63):e4031. PubMed ID: 22664962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus.
    Kahl CA; Marsh J; Fyffe J; Sanders DA; Cornetta K
    J Virol; 2004 Feb; 78(3):1421-30. PubMed ID: 14722297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.
    Mochizuki H; Schwartz JP; Tanaka K; Brady RO; Reiser J
    J Virol; 1998 Nov; 72(11):8873-83. PubMed ID: 9765432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel bovine lentiviral vectors based on Jembrana disease virus.
    Metharom P; Takyar S; Xia HH; Ellem KA; Macmillan J; Shepherd RW; Wilcox GE; Wei MQ
    J Gene Med; 2000; 2(3):176-85. PubMed ID: 10894263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
    Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
    J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic improvement of lentivirus transduction protocols by antibody fragments fused to VSV-G as envelope glycoprotein.
    Höfig I; Barth S; Salomon M; Jagusch V; Atkinson MJ; Anastasov N; Thirion C
    Biomaterials; 2014 Apr; 35(13):4204-12. PubMed ID: 24529898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.